Abstract:4156 Background: The hedgehog pathway plays a critical role in embryonic development, tissue polarity and carcinogenesis. It is estimated that activation of this pathway is associated with almost all basal cell carcinomas and in nearly 30% of non-skin cancers. Whereas mutations of human homologue of patched 1 (PTCH1), smoothened (SMO) or suppressor of fused [Su(Fu)] contribute to the development of BCCs and medulloblastomas, whereas elevated expression of the ligands- hedgehog molecules may be responsible for activation of hedgehog signaling in prostate, breast, lung and gastrointestinal cancers. However, the molecular basis for SMO signaling regulation, the essential event in pathway activation, remains unclear. Therefore, identification of novel regulators of SMO will further our understanding of hedgehog-mediated carcinogenesis. Results: Through yeast two hybrid screening using SMO as bait, we identified a Smooothened Interacting Protein, SIP. In cultured cells, we showed that SIP co-immunoprecipitated reciprocally with SMO. Using GST pull-down studies, we showed that the cytoplasmic tail of SMO is responsible for the interaction with SIP. We found that stability of SMO protein, but not Gli1 protein, can be enhanced with ectopic expression of SIP in a dose-dependent manner. To demonstrate whether inactivation of SIP is sufficient to inhibit growth of cancer cells with activated hedgehog signaling, we treated cancer cell lines with SIP siRNA or control siRNA and measured DNA synthesis and softagar growth. We found that SIP siRNA inhibited DNA synthesis and softagar growth of PLC/PRF/5 cells, which have activated hedgehog signaling, but had no effects on HepG2 cells, which have no detectable hedgehog signaling. Conclusion: We have identified a novel regulator of SMO, SIP. We find that SMO interacts with SIP through its c-terminal tail. The protein stability of SMO is enhanced by the presence of SIP. Inactivation of SIP by specific siRNA, just like SMO antagonist cyclopamine, reduced DNA synthesis and cell growth of cancer cells with activated hedgehog signaling. Thus, targeted inhibition of SIP may have significant implications in cancer therapeutics.

Small-molecule modulators of the Sonic Hedgehog signaling pathway

A small molecule that binds Hedgehog and blocks its signaling in human cells

An Epigenetic Switch Induced by Shh Signalling Regulates Gene Activation During Development and Medulloblastoma Growth

Discovery and evaluation of potential sonic hedgehog signaling pathway inhibitors using pharmacophore modeling and molecular dynamics simulations

Discovery of Small Molecule Inhibitors Targeting the Sonic Hedgehog

MEKK2 and MEKK3 Suppress Hedgehog Pathway-Dependent Medulloblastoma by Inhibiting GLI1 Function

Regulation of Smoothened Phosphorylation and High-Level Hedgehog Signaling Activity by a Plasma Membrane Associated Kinase

Novel-smoothened Inhibitors for Therapeutic Targeting of Naïve and Drug-Resistant Hedgehog Pathway-Driven Cancers.

Progress in Research on Small Molecular Inhibitors of Hedgehog Signal Pathway

Current Status of Hedgehog Signaling Inhibitors

Identification of small molecule antagonists of sonic hedgehog/heparin binding with activity in hedgehog functional assays

Discovery of Potent and Novel Smoothened Antagonists Via Structure-Based Virtual Screening and Biological Assays.

Progress in research of novel anticancer drugs targeting Hedgehog signaling pathway

Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation

Identification of a Novel Regulator for Smoothened Signaling in Human Cancers

Hedgehog signaling is controlled by Rac1 activity

Converse Conformational Control of Smoothened Activity by Structurally Related Small Molecules

Hedgehog Regulates Smoothened Activity by Inducing a Conformational Switch

Discovery of Novel Macrocyclic Hedgehog Pathway Inhibitors Acting by Suppressing the Gli-Mediated Transcription.

Pharmacological modulation of Sonic Hedgehog signaling pathways in Angiogenesis: A mechanistic perspective

Hedgehog Signalling Activity of Smoothened Requires Phosphorylation by Protein Kinase A and Casein Kinase I